Hindustan Foods Limited
NSE: HNDFDSDiversified FMCG
Share price
₹572.60
-1.34% close of 8 Oct 2026
Business score
How strong the business is, in one number. The parts behind it are in Pro.
67
out of 100 · worked out 8 Oct 2026
Your ratios
The numbers you want to see first. Tap Edit to change them.
Market cap
₹6,871 Cr
P/E ratio
42.5
P/B ratio
5.9
ROCE
14.1%
ROE
14.6%
Dividend yield
0.0%
Price & valuation chart
How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.
Answers
Simple answers to the questions investors ask most, from the company's own numbers.
How fast it has been growing
Our sales figures for this company step up at Mar 2017 and we hold nothing that says why, so we cannot honestly quote a growth rate across it.
Whether it grew faster than its sector
Our sales figures for this company step up at Mar 2017 and we hold nothing that says why, so there is no honest growth rate of its own to set against its sector.
Room to re-rate, or risk of de-rating
At 42.5× earnings it costs 1.8× the market, which pays 23.9× across 2199 companies we can price. Its own industry sits at 39.1×, across 4 companies. It is against its own five-year median of 69.1×, the 5th percentile of its own range.
Whether growth justifies the valuation
Priced at 1.5 times its growth rate, on earnings growth of 29%.
| Profit growth | Price per ₹1 profit | Per 1% growth | |
|---|---|---|---|
| Hindustan Foods Limited — this one | 29%/yr | 42.5× | ₹1.5 |
| Hindustan Unilever | 14%/yr | 39.3× | ₹2.8 |
| ITC Limited | 3%/yr | 16.2× | ₹5.4 |
| Godavari Biorefineries Limited | 17%/yr | 38.9× | ₹2.3 |
| Davangere Sugar Company Limited | -14%/yr | 47.5× | — |
Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
How it compares with its peers
Against companies the exchange files under the same label (Diversified FMCG), it ranks 3 of 5 on returns, 1 of 5 on growth, 4 of 5 on margin. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
What makes it hard to beat — and is that still true?
No durable advantage shows in the numbers: it earns 14.1% on capital, ahead of 40% of companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
Whether its growth pays for itself
No — Over the last five years it made ₹440 crore of cash from the business but spent ₹994 crore on plant and equipment, ₹554 crore more than it made; the gap was mostly borrowed — borrowings rose from ₹350 crore to ₹1088 crore. And the profit is real: of every 100 rupees it reported over 8 years, about 97 arrived as cash. Its cash comes back more slowly than it used to: it went from being waiting 4 days for its cash to waiting 36 days for its cash.
Profit reality check
Is the profit real cash? Simple checks on the accounts. Facts only, not advice.
7 of 9 checks clear · 78%
Latest result · Q1 FY27
What the last results showed. Whether management kept its word is in Pro.
Announced 4 Aug 2026 · Consolidated · Unaudited
Revenue
₹1,201 Cr
Revenue vs last year
+17.9%
Revenue vs last quarter
+7.5%
Net profit
₹43 Cr
Profit vs last year
+33.6%
Profit vs last quarter
+1.8%
Net margin
3.6%
EPS
₹3.53
Earnings call transcript · 5 Aug 2026
Checklist before you investPRO
Points for and against, in one list.
Key numbers & peers
The main numbers grouped by topic, and how the company compares with similar ones.
Price
- Market cap
- ₹6,871 Cr
- Prev close
- ₹572.60
- 52w High
- ₹678
- 52w Low
- ₹442
- Enterprise value
- ₹7,907 Cr
- Beta
- 0.7
- Price CAGR 1y
- 9.0%
- Price CAGR 3y
- 3.0%
- Price CAGR 5y
- 7.0%
- Price CAGR 10y
- 39.0%
Ratios
- Return on assets
- 4.7%
- PEG ratio
- 1.5
- P/E ratio
- 42.5
- P/B ratio
- 5.9
- EV / EBITDA
- 20.8
- Industry P/E
- 39.4
- ROCE
- 14.1%
- ROCE 5y average
- 15.6%
- ROE
- 14.6%
- Debt / Equity
- 0.9
- Interest coverage
- 3.4
- Dividend yield
- 0.0%
- ROE 3y average
- 15.0%
- ROE last year
- 15.0%
Annual P&L
- Annual revenue
- ₹4,251 Cr
- Annual profit
- ₹149 Cr
- Operating margin
- 9.0%
- Net profit margin
- 3.5%
- EBITDA margin
- 8.5%
- Sales growth 3y
- 17.8%
- Sales growth 5y
- 25.1%
- Profit growth 3y
- 29.0%
- Profit growth 5y
- 35.0%
- EPS
- ₹12.5
- Sales growth TTM
- 18.0%
- Profit growth TTM
- 40.0%
- Dividend payout
- 0.0%
Quarter P&L
- Sales latest quarter
- ₹1,201 Cr
- Profit latest quarter
- ₹43 Cr
- YoY quarterly sales growth
- 17.9%
- YoY quarterly profit growth
- 34.4%
- OPM latest quarter
- 8.3%
Balance Sheet
- Book Value
- ₹97.1
- Face Value
- ₹2.0
- Total debt
- ₹1,088 Cr
- Total cash
- ₹52 Cr
- Borrowings
- ₹1,088 Cr
- Reserves / Equity
- 47.5
Cash Flow
- Operating cash flow
- ₹100 Cr
- Free cash flow
- -₹225 Cr
- FCF yield
- -4.5%
- Net cash flow
- -₹44 Cr
Shareholding
- Promoter holding
- 61.8%
- FII holding
- 5.9%
- DII holding
- 14.7%
- Public holding
- 17.6%
Peer comparison
| Company | Price ₹ | P/E | Mkt cap ₹ Cr | Div yield % | Profit qtr ₹ Cr | Profit var % | Sales qtr ₹ Cr | Sales var % | ROCE % |
|---|---|---|---|---|---|---|---|---|---|
| Hind. Unilever | 1,865.40 | 39.8 | 4,38,293 | 2.20 | 2,680.0 | -3.7 | 17,341.0 | 10.1 | 28.4 |
| ITC | 265.70 | 16.9 | 3,32,936 | 5.46 | 4,508.8 | -22.0 | 19,114.4 | -11.1 | 38.9 |
| Hindustan Foods | 580.40 | 43.5 | 7,041 | 0.00 | 42.8 | 32.8 | 1,201.1 | 17.9 | 14.1 |
| Godavari Bioref. | 226.24 | 39.9 | 1,158 | 0.00 | -19.3 | -20.6 | 557.9 | 4.6 | 6.4 |
| Davangere Sugar | 2.36 | 49.2 | 400 | 0.00 | 0.9 | -27.7 | 34.7 | 44.3 | 5.5 |
| Median | 265.70 | 39.9 | 7,041 | 0.00 | 42.8 | -20.6 | 1,201.1 | 10.1 | 14.1 |
Competes with: Davangere Sugar Company Limited, Godavari Biorefineries Limited, Hindustan Unilever, ITC Limited
Quarterly results
Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.
| Line item | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 619 | 675 | 729 | 731 | 868 | 883 | 880 | 959 | 1,019 | 1,039 | 1,044 | 1,117 | 1,201 |
| Expenses | 569 | 621 | 672 | 670 | 795 | 813 | 806 | 880 | 938 | 953 | 949 | 1,017 | 1,101 |
| Material Cost | 724 | 779 | 823 | 767 | 895 | 964 | |||||||
| Change in Inventories | 0.15 | 2.77 | -7.40 | 10 | -26 | -28 | |||||||
| Purchases of Stock-in-Trade | 0.14 | 0.05 | 0.49 | 0.09 | 0 | 0.14 | |||||||
| Employee Cost | 63 | 63 | 62 | 60 | 65 | 69 | |||||||
| Other Expenses | 68 | 71 | 75 | 70 | 83 | 95 | |||||||
| Operating Profit | 50 | 54 | 57 | 61 | 73 | 70 | 73 | 78 | 81 | 86 | 95 | 100 | 100 |
| OPM % | 8.15 | 7.99 | 7.79 | 8.29 | 8.37 | 7.91 | 8.32 | 8.18 | 7.93 | 8.25 | 9.08 | 8.93 | 8.35 |
| Other Income | 1 | 2 | 1 | 3 | 3 | 3 | 6 | 3 | 3 | 4 | -2 | 3 | 6 |
| Exceptional items (within Other Income) | 0 | 0 | 0 | -3.50 | -1.07 | 0 | |||||||
| Interest | 11 | 13 | 15 | 18 | 20 | 21 | 20 | 20 | 20 | 20 | 19 | 23 | 23 |
| Depreciation | 11 | 12 | 14 | 18 | 20 | 20 | 20 | 20 | 21 | 22 | 23 | 23 | 26 |
| Profit before tax | 29 | 31 | 29 | 28 | 36 | 32 | 39 | 42 | 43 | 47 | 51 | 57 | 57 |
| Tax % | 21 | 21 | 24 | 17 | 25 | 28 | 27 | 24 | 25 | 26 | 23 | 27 | 24 |
| Net Profit | 23 | 25 | 22 | 23 | 27 | 23 | 29 | 32 | 32 | 35 | 39 | 42 | 43 |
| EPS in Rs | 2.07 | 2.19 | 1.95 | 2 | 2.38 | 2 | 2.44 | 2.69 | 2.70 | 2.95 | 3.24 | 3.48 | 3.53 |
| Diluted EPS in Rs | 2.62 | 2.69 | 2.95 | 3.02 | 3.43 | 3.53 |
Profit & loss
Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.
| Line item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 492 | 772 | 1,386 | 2,040 | 2,598 | 2,755 | 3,639 | 4,251 | 4,400 |
| Expenses | 459 | 717 | 1,305 | 1,927 | 2,425 | 2,533 | 3,339 | 3,888 | 4,020 |
| Material Cost | 2,829 | 3,349 | |||||||
| Change in Inventories | -38 | -22 | |||||||
| Purchases of Stock-in-Trade | 0.61 | 0.63 | |||||||
| Employee Cost | 222 | 253 | |||||||
| Other Expenses | 257 | 307 | |||||||
| Operating Profit | 33 | 55 | 81 | 113 | 173 | 222 | 300 | 363 | 380 |
| OPM % | 7 | 7 | 6 | 6 | 7 | 8 | 8 | 9 | 9 |
| Other Income | 1 | 1 | 3 | 4 | 5 | 7 | 17 | 9 | 12 |
| Exceptional items (within Other Income) | 0 | -4.57 | |||||||
| Interest | 8 | 11 | 19 | 20 | 36 | 57 | 81 | 82 | 85 |
| Depreciation | 7 | 11 | 17 | 25 | 37 | 55 | 80 | 90 | 95 |
| Profit before tax | 18 | 34 | 48 | 71 | 104 | 117 | 155 | 200 | 212 |
| Tax % | 35 | 35 | 28 | 38 | 32 | 21 | 26 | 25 | |
| Net Profit | 12 | 22 | 34 | 45 | 71 | 93 | 115 | 149 | 158 |
| EPS in Rs | 1.76 | 2.07 | 3.25 | 3.96 | 6.31 | 8.12 | 9.81 | 12 | 13 |
| Diluted EPS in Rs | 9.51 | 12 | |||||||
| Dividend Payout % | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
Compounded growth
Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.
Compounded sales growth
- 10 years
- —
- 5 years
- 25%
- 3 years
- 18%
- TTM
- 18%
Compounded profit growth
- 10 years
- —
- 5 years
- 35%
- 3 years
- 29%
- TTM
- 40%
Stock price CAGR
- 10 years
- 39%
- 5 years
- 7%
- 3 years
- 3%
- 1 year
- 9%
Return on equity
- 10 years
- —
- 5 years
- 16%
- 3 years
- 15%
- Last year
- 15%
Balance sheet
What the company owns and what it owes, at the end of each year. ₹ crore.
| Line item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13 | 21 | 21 | 23 | 23 | 23 | 24 | 24 |
| Reserves | 51 | 165 | 199 | 281 | 352 | 623 | 896 | 1,140 |
| Borrowings | 100 | 165 | 218 | 350 | 516 | 727 | 896 | 1,088 |
| Other Liabilities | 102 | 188 | 256 | 331 | 445 | 552 | 727 | 913 |
| Minority Interest | 0 | |||||||
| Total Liabilities | 266 | 539 | 694 | 984 | 1,335 | 1,924 | 2,544 | 3,166 |
| Fixed Assets | 133 | 250 | 271 | 427 | 554 | 908 | 1,041 | 1,302 |
| CWIP | 0 | 26 | 53 | 87 | 125 | 9 | 120 | 150 |
| Investments | -0 | 2 | 0 | -0 | -0 | -0 | -0 | 5 |
| Other Assets | 133 | 261 | 370 | 470 | 656 | 1,007 | 1,383 | 1,709 |
| Total Assets | 266 | 539 | 694 | 984 | 1,335 | 1,925 | 2,552 | 3,174 |
Cash flows
Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.
| Line item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -5 | 17 | 74 | 36 | 99 | 87 | 118 | 100 |
| Cash from Investing Activity | -40 | -145 | -92 | -139 | -220 | -381 | -291 | -339 |
| Cash from Financing Activity | 43 | 153 | 34 | 91 | 128 | 298 | 209 | 196 |
| Net Cash Flow | -2 | 24 | 16 | -12 | 7 | 3 | 37 | -44 |
| Free Cash Flow | -46 | -111 | -5 | -104 | -65 | -46 | -114 | -225 |
Ratios
How fast customers pay, how long stock sits, and how well capital earns — year by year.
| Line item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 32 | 18 | 13 | 13 | 15 | 23 | 21 | 22 |
| Inventory Days | 54 | 74 | 58 | 56 | 68 | 98 | 122 | 131 |
| Days Payable | 84 | 94 | 74 | 64 | 69 | 85 | 87 | 86 |
| Cash Conversion Cycle | 2 | -2 | -2 | 5 | 14 | 37 | 56 | 68 |
| Working Capital Days | -8 | 7 | 5 | 4 | 6 | 17 | 31 | 36 |
| ROCE % | 17 | 17 | 17 | 18 | 15 | 14 | 14 |
Price trend
The price as a Renko brick chart: small moves drop out so the bigger path stands out.
Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.
Open interestPRO
Where option traders are positioned on this stock.
Industry numbers
The numbers that matter most in this industry, from the company's own filings.
1 when an audit qualification is filed as repetitive
0.00flag
2026-03-31
the company's own unlisted debt securities in default at period end
0.00cr
2026-06-30
the company's own loans / revolving facilities in default at period end (standalone filing)
0.00cr
2026-06-30
net debt from the filed balance sheet at the newest year end: Borrowings − Cash Equivalents − Investments (Current); negative = net cash
1,036inr_cr
2026-03-31
guarantees / comfort given for promoter, promoter group, directors and KMP
0.00cr
2026-03-31
loans outstanding to promoter, promoter group, directors and KMP (governance filing)
0.00cr
2026-03-31
security given for the borrowing of promoter, promoter group, directors and KMP
0.00cr
2026-03-31
FY revenue / permanent employees + workers, same basis (calc)
1,99,00,486inr
2026-03-31
News
News and filings about Hindustan Foods Limited. Open one to see why it matters.
No recent news for this company.
Supply chain
Who it buys from, sells to and competes with — as recorded in our map of company links.
Competes with
Uses as raw material
- cereals and grains (baby food, cereals, snacks)
- detergent, personal-care and home-care chemical inputs
- leather, uppers, soles and footwear accessories
- malt-based food ingredients
- milk solids and frozen-dessert/ice-cream ingredients
- packaging materials
- talc and cosmetic/personal-care inputs
- tea and coffee
Sells to
- Hindustan Unilever · FMCG contract manufacturing (tea/coffee blending & packing, malt-based foods, legacy footw…
- Reckitt Benckiser · home-care / personal-care contract manufacturing (Baddi plant acquired from Reckitt per Q4…
About
What the company is, from our own records: where it sits, where it makes things, and what it is made of.
- Sector
- Fast Moving Consumer Goods
- Industry
- Diversified FMCG
- Classification
- Fast Moving Consumer Goods › Diversified FMCG
- ISIN
- INE254N01026
Plants
- Aurangabad beverage plant
- Baddi plant · Baddi, Himachal Pradesh
- Coimbatore plant
- Goa plant
- Guwahati plant · Guwahati, Assam
- Hyderabad plant cluster
- Jammu plant · Jammu / Samba, Jammu & Kashmir
- Kundli plant cluster
- Lucknow plant · Lucknow, Uttar Pradesh
- Mysuru plant
- Nashik plant · Nashik, Maharashtra
- Panipat plant · Panipat, Haryana
- Paonta Sahib plant cluster
- Silvassa integrated FMCG plant
News impact
Big market events that reach Hindustan Foods Limited, and how the effect spreads.
1 Oct, 14:20 IST · Market event · medium impact
Russia steps up sunflower oil exports to China as war disrupts India trade
Russia is diverting sunflower cooking oil to China as war disrupts sea shipments to India, squeezing Indian oil makers like AWL while shoppers face higher prices.
Who it hits first
- Russia is sending more of its sunflower cooking oil to China by land while war disrupts the sea shipments that supply India.
- India's sunflower oil imports are expected to fall to 1.1 million tonnes this year from 1.5 million tonnes last year, a cut of about 27%.
- Indian cooking-oil makers such as AWL Agri Business, Patanjali Foods and Gokul Agro face costlier or scarcer raw oil, squeezing their thin refining margins.
- Shoppers face higher cooking-oil prices if makers pass the cost through; the pack's keyword match to crude-oil patterns is spurious (this is edible oil, not crude), so no wider energy chain follows.
Who may gain
- Chinese buyers and refiners: steadier Russian sunflower supply arriving by land.
- Alternative oil suppliers in palm, soybean and mustard: Indian buyers substitute toward their oils as sunflower tightens.
- Domestic oilseed farmers and crushers: tighter imports lift local oilseed prices.
Along the supply chain
Downstream
Downstream, AWL has no listed customers in the graph, but kirana shops and households ultimately pay more per litre if refiners pass through the higher import cost.
Upstream
Upstream, Russian sunflower crushers redirect barrels to China, while AWL's domestic suppliers such as Renuka, KN Agri and MGEL keep steady orders for their own goods since the lost input is imported sunflower oil.
Where demand moves
Business
Business demand for cooking oil holds steady, but supply shifts: Indian refiners scramble for costlier non-Russian sunflower or substitute oils, while Chinese buyers absorb the diverted Russian barrels.
Capital
Capital turns cautious on thin-margin edible-oil refiners such as AWL and Gokul Agro until import flows stabilise, with no spillover to the wider food sector.
How it spreads across sectors
Fast Moving Consumer Goods
Edible-oil refiners face margin pressure from a roughly 27% import cut, while the rest of the food, personal-care and liquor shelf is untouched.
A pattern seen before
Cascade chain
Pattern name
Crude Oil Cascade
Patterns
- Crude Oil Cascade
- China Cascade
Sectors queried
- Cement
- Chemicals
- FMCG
- Pharma
- Power
- Textiles
When it plays out
Immediate
Edible-oil shares soften on margin fears; wholesale sunflower prices start firming.
Medium term
Trade reroutes through other origins or war-risk easing normalises flows; refiner margins recover.
Short term
Import arrivals run about 27% below last year; refiners blend costlier substitutes and test price hikes.
16 Sept, 11:24 IST · Market event · high impact
Godavari Biorefineries jumps nearly 10% after Chinese patent grant for antiviral compound
Godavari Biorefineries won a Chinese patent for compounds used to make antiviral medicines, so its shares jumped ~10% as investors bet on future earnings, while rival chemical makers face a new patented competitor.
Who it hits first
- Godavari Biorefineries' biotech arm Sathgen Therapeutics won a Chinese patent for compounds that block a cell process (V-ATPase) to make antiviral medicines, giving it exclusive rights in China it could license out or develop.
- Investors repriced the stock nearly 10% higher the same day — but no buyer, licensing deal, timeline or revenue figure came with the announcement, so the gain is a bet on future money, not money in hand.
Who may gain
- Godavari Biorefineries itself is the winner: a granted China patent it can license for fees or use to make future drugs.
- Nobody else clearly gains — the patent walls rivals OUT of these compounds in China rather than sharing any benefit, and no listed drug maker tied to these compounds was named.
Along the supply chain
Downstream
No downstream change today — ethanol buyers (Indian Oil, HPCL, BPCL) and sugar customers see identical supply and prices; only a future drug maker licensing these compounds would one day become a new downstream link.
Upstream
No upstream change — the patent alters nothing Godavari buys (sugarcane, molasses, chemical inputs), so no supplier gains or loses an order.
Where demand moves
Business
No goods or orders move here — a patent grant shifts no supply and creates no purchase orders; it only creates future licensing possibility.
Capital
Short-term trading money may pile into Godavari Biorefineries for a few days on the headline, as it did after its last three patent wins; no wider sector rotation — the FMCG giants sharing its sector label are untouched.
How it spreads across sectors
Chemicals
Mild positive mood signal for Indian bio-chemical innovators — a China patent shows home-grown R&D can win abroad — but no earnings change for any listed chemical maker.
Fast Moving Consumer Goods
No effect — Godavari's sector-mates ITC, Hindustan Unilever, Hindustan Foods and Davangere Sugar share only a database label, and their closes never reacted to its three prior patent wins.
Healthcare
No near-term effect — turning these compounds into approved antiviral drugs needs years of trials and partners that do not exist yet; none of the listed drug makers are named in this story.
When it plays out
Immediate
Godavari shares hold most of the ~10% pop for a few sessions on headline momentum, then drift as traders take profits (its last three patent pops faded within days).
Medium term
Over 1-6 months the patent only matters if Sathgen signs a licensing or co-development deal for the antiviral compounds; otherwise the stock reverts to sugar-ethanol-chemical earnings, where thin margins (operating margin 6% vs sector median 10%) cap any re-rating.
Short term
Over 1-4 weeks the pop typically leaks away without a licensing announcement — two of the last three wins sat -2% to -5% within a week (the third held flat); only a named licensee changes that path.
Dividends, splits & big trades
Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.
Dividends
| 21 Jul 2022 | split | ₹0 |
|---|
Splits, bonuses & buybacks
- daily-prices repair: 5 rows from NSE's archive (replace 0, delete 0, insert 5), 2023-11-12..2026-02-01 (docs/flat_day_repair.md)1× · 12 Nov 2023
Insider trades
| Disclosed | Who | Type | Shares | Value ₹ Cr |
|---|---|---|---|---|
| 26 Aug 2026 | Bhairavi Prashant Sharma · Other | SELL | 2,500 | 0.16 |
Documents
Annual reports, results presentations and earnings calls, straight from the source.
- Annual report · 2025-2626 Aug 2026
- Earnings call5 Aug 2026
- Results presentation30 Jun 2026
- Earnings call22 May 2026
- Earnings call11 Feb 2026
- Annual report · 2024-2525 Aug 2025
Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.